Squawk Pod Reports from Davos: Moderna’s Stephane Bancel 01/21/23

Squawk Pod

CNBC

News, Business News, Business, Investing

4.2 • 543 Ratings

🗓️ 21 January 2023

⏱️ 14 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In a special episode of Squawk Pod, Joe Kernen, Becky Quick, and Andrew Ross Sorkin are at the World Economic Forum in Davos, Switzerland, where they’re speaking with Moderna CEO Stephane Bancel. Three years after the first case of Covid-19 was detected in the United States, Bancel recalls the journey to vaccinating the global public, and Moderna’s newest vaccine trials for RSV. In this episode: Stephane Bancel, @moderna_tx Becky Quick @BeckyQuick Joe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkin Cameron Costa, @CameronCostaNY

Transcript

Click on a timestamp to play from that location

0:00.0	We currently have in a clinic a COVID booster and flu booster in one
0:08.0	doors a COVID booster flu booster and RSV people don't even remember now.
0:12.7	Did I get a COVID shot this winter or a full shot?
0:15.6	Moderna CEO, Stephen Bonsell,
0:18.1	at the World Economic Forum in Davos, Switzerland.
0:21.0	Back in person in January, for the first time since his team started working
0:26.2	on the COVID vaccine, deploying MRNA technology.
0:30.4	The technology is quite special.
0:32.3	How far we've come in the fight against COVID-19 and the next virus Moderna is taking on.
0:38.0	We started the phase one for the ours vaccine in January 2021, just after the COVID-19 vaccine was approved.
0:45.0	And here we are just 24 months after we are announcing phase three positive data.
0:50.0	The golden age of vaccines has begun and it's happening in and out of the lab.
0:56.0	I think governments and industry have to work with together.
0:59.0	We are of course a scientific and academic community to figure out how do we educate people how do we share the real
1:03.9	world evidence I'm cinevise producer Cameron Costa squawk pad reports from Davos
1:09.1	Modernas Stefan Bonsell begins right now. It's our final episode covering the 2023 World Economic Forum in Davos, Switzerland.
1:29.0	And this week a lot of news has been made.
1:31.5	One such piece of news promising results from Pfizer and Moderna's
1:36.0	RSV vaccine trials. So promising in fact that both companies expect expedited approval for their
1:42.4	respective vaccines from the FDA.
1:44.7	The last time we were at Davos in January, we were also talking about drug makers and public health.
1:50.9	But it was three years ago, the very beginning of 2020.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.